AAPL337.02-2.73 (-0.80%) ▼|ABBV265.08-0.13 (-0.05%) ▼|ABT103.49-0.20 (-0.19%) ▼|ACN183.52-0.20 (-0.11%) ▼|ADBE240.69+2.44 (+1.02%) ▲|AMAT474.38+1.92 (+0.41%) ▲|AMD614.61-9.16 (-1.47%) ▼|AMGN406.09-4.15 (-1.01%) ▼|AMT170.78-4.47 (-2.55%) ▼|AMZN249.27-5.71 (-2.24%) ▼|AVGO354.99-9.55 (-2.62%) ▼|AXP301.96-3.11 (-1.02%) ▼|BA199.93+2.21 (+1.12%) ▲|BAC56.00-0.20 (-0.36%) ▼|BKNG155.90-8.32 (-5.07%) ▼|BLK1,060.89-5.77 (-0.54%) ▼|BMY61.15-1.10 (-1.77%) ▼|BNY149.51-0.66 (-0.44%) ▼|BRK-B507.17+3.68 (+0.73%) ▲|C131.93-0.54 (-0.41%) ▼|CAT812.02+4.01 (+0.50%) ▲|CL85.93-1.12 (-1.29%) ▼|CMCSA22.55+0.13 (+0.58%) ▲|COF196.10-4.45 (-2.22%) ▼|COP128.09+2.82 (+2.25%) ▲|COST904.70+5.29 (+0.59%) ▲|CRM237.58+4.30 (+1.84%) ▲|CSCO106.43-0.01 (-0.01%) ▼|CVS85.86-1.24 (-1.42%) ▼|CVX205.51+3.10 (+1.53%) ▲|DE709.48+6.36 (+0.90%) ▲|DHR221.56+0.47 (+0.21%) ▲|DIS103.46-0.36 (-0.35%) ▼|DUK114.17-2.14 (-1.84%) ▼|EMR154.59+0.40 (+0.26%) ▲|FDX291.50-4.44 (-1.50%) ▼|GD343.33-0.06 (-0.02%) ▼|GE319.80+0.58 (+0.18%) ▲|GEV951.82+1.54 (+0.16%) ▲|GILD151.37-1.30 (-0.85%) ▼|GM83.77+0.32 (+0.38%) ▲|GOOG334.98-12.43 (-3.58%) ▼|GOOGL337.83-13.33 (-3.80%) ▼|GS936.36-13.13 (-1.38%) ▼|HD296.72-8.63 (-2.83%) ▼|HON212.57+0.72 (+0.34%) ▲|IBM232.76+1.38 (+0.60%) ▲|INTC122.60-1.26 (-1.02%) ▼|INTU286.80-5.55 (-1.90%) ▼|ISRG398.30-3.79 (-0.94%) ▼|JNJ269.17-0.02 (-0.01%) ▼|JPM337.53-2.47 (-0.73%) ▼|KO88.09-0.52 (-0.59%) ▼|LIN469.72+4.81 (+1.03%) ▲|LLY1,150.99-19.15 (-1.64%) ▼|LMT524.68+2.34 (+0.45%) ▲|LOW191.36-4.72 (-2.41%) ▼|LRCX307.28-3.35 (-1.08%) ▼|MA559.92+4.03 (+0.73%) ▲|MCD238.32-12.03 (-4.81%) ▼|MDLZ61.44+0.36 (+0.59%) ▲|MDT89.30-1.47 (-1.62%) ▼|META744.10+7.51 (+1.02%) ▲|MMM170.30+1.00 (+0.59%) ▲|MO68.95+0.31 (+0.45%) ▲|MRK148.08-2.83 (-1.88%) ▼|MS198.39-1.79 (-0.89%) ▼|MSFT500.59+2.59 (+0.52%) ▲|MU1,071.88-24.28 (-2.22%) ▼|NEE77.02-2.24 (-2.83%) ▼|NFLX71.36-0.80 (-1.11%) ▼|NKE36.05-0.05 (-0.14%) ▼|NOW140.78+3.78 (+2.76%) ▲|NVDA225.51-3.36 (-1.47%) ▼|ORCL144.56-4.64 (-3.11%) ▼|PEP130.18-1.01 (-0.77%) ▼|PFE28.18+0.25 (+0.90%) ▲|PG147.39-0.83 (-0.56%) ▼|PLTR191.79+6.80 (+3.68%) ▲|PM190.84+0.61 (+0.32%) ▲|QCOM197.24-1.03 (-0.52%) ▼|RTX192.19+1.20 (+0.63%) ▲|SBUX94.14-0.97 (-1.02%) ▼|SCHW99.50-0.85 (-0.85%) ▼|SO83.47-1.68 (-1.97%) ▼|SPG204.16-1.79 (-0.87%) ▼|T25.30+0.20 (+0.80%) ▲|TMO665.30+6.78 (+1.03%) ▲|TMUS165.66+3.25 (+2.00%) ▲|TSLA380.12+1.22 (+0.32%) ▲|TXN272.62+1.21 (+0.45%) ▲|UBER69.42-0.47 (-0.67%) ▼|UNH371.29-1.66 (-0.45%) ▼|UNP275.53+1.12 (+0.41%) ▲|UPS95.82-0.05 (-0.05%) ▼|USB58.48-0.96 (-1.62%) ▼|V361.52-0.52 (-0.14%) ▼|VZ46.52+0.07 (+0.15%) ▲|WFC81.90-1.25 (-1.50%) ▼|WMT110.53+0.41 (+0.37%) ▲|XOM161.23+2.52 (+1.59%) ▲|AAPL337.02-2.73 (-0.80%) ▼|ABBV265.08-0.13 (-0.05%) ▼|ABT103.49-0.20 (-0.19%) ▼|ACN183.52-0.20 (-0.11%) ▼|ADBE240.69+2.44 (+1.02%) ▲|AMAT474.38+1.92 (+0.41%) ▲|AMD614.61-9.16 (-1.47%) ▼|AMGN406.09-4.15 (-1.01%) ▼|AMT170.78-4.47 (-2.55%) ▼|AMZN249.27-5.71 (-2.24%) ▼|AVGO354.99-9.55 (-2.62%) ▼|AXP301.96-3.11 (-1.02%) ▼|BA199.93+2.21 (+1.12%) ▲|BAC56.00-0.20 (-0.36%) ▼|BKNG155.90-8.32 (-5.07%) ▼|BLK1,060.89-5.77 (-0.54%) ▼|BMY61.15-1.10 (-1.77%) ▼|BNY149.51-0.66 (-0.44%) ▼|BRK-B507.17+3.68 (+0.73%) ▲|C131.93-0.54 (-0.41%) ▼|CAT812.02+4.01 (+0.50%) ▲|CL85.93-1.12 (-1.29%) ▼|CMCSA22.55+0.13 (+0.58%) ▲|COF196.10-4.45 (-2.22%) ▼|COP128.09+2.82 (+2.25%) ▲|COST904.70+5.29 (+0.59%) ▲|CRM237.58+4.30 (+1.84%) ▲|CSCO106.43-0.01 (-0.01%) ▼|CVS85.86-1.24 (-1.42%) ▼|CVX205.51+3.10 (+1.53%) ▲|DE709.48+6.36 (+0.90%) ▲|DHR221.56+0.47 (+0.21%) ▲|DIS103.46-0.36 (-0.35%) ▼|DUK114.17-2.14 (-1.84%) ▼|EMR154.59+0.40 (+0.26%) ▲|FDX291.50-4.44 (-1.50%) ▼|GD343.33-0.06 (-0.02%) ▼|GE319.80+0.58 (+0.18%) ▲|GEV951.82+1.54 (+0.16%) ▲|GILD151.37-1.30 (-0.85%) ▼|GM83.77+0.32 (+0.38%) ▲|GOOG334.98-12.43 (-3.58%) ▼|GOOGL337.83-13.33 (-3.80%) ▼|GS936.36-13.13 (-1.38%) ▼|HD296.72-8.63 (-2.83%) ▼|HON212.57+0.72 (+0.34%) ▲|IBM232.76+1.38 (+0.60%) ▲|INTC122.60-1.26 (-1.02%) ▼|INTU286.80-5.55 (-1.90%) ▼|ISRG398.30-3.79 (-0.94%) ▼|JNJ269.17-0.02 (-0.01%) ▼|JPM337.53-2.47 (-0.73%) ▼|KO88.09-0.52 (-0.59%) ▼|LIN469.72+4.81 (+1.03%) ▲|LLY1,150.99-19.15 (-1.64%) ▼|LMT524.68+2.34 (+0.45%) ▲|LOW191.36-4.72 (-2.41%) ▼|LRCX307.28-3.35 (-1.08%) ▼|MA559.92+4.03 (+0.73%) ▲|MCD238.32-12.03 (-4.81%) ▼|MDLZ61.44+0.36 (+0.59%) ▲|MDT89.30-1.47 (-1.62%) ▼|META744.10+7.51 (+1.02%) ▲|MMM170.30+1.00 (+0.59%) ▲|MO68.95+0.31 (+0.45%) ▲|MRK148.08-2.83 (-1.88%) ▼|MS198.39-1.79 (-0.89%) ▼|MSFT500.59+2.59 (+0.52%) ▲|MU1,071.88-24.28 (-2.22%) ▼|NEE77.02-2.24 (-2.83%) ▼|NFLX71.36-0.80 (-1.11%) ▼|NKE36.05-0.05 (-0.14%) ▼|NOW140.78+3.78 (+2.76%) ▲|NVDA225.51-3.36 (-1.47%) ▼|ORCL144.56-4.64 (-3.11%) ▼|PEP130.18-1.01 (-0.77%) ▼|PFE28.18+0.25 (+0.90%) ▲|PG147.39-0.83 (-0.56%) ▼|PLTR191.79+6.80 (+3.68%) ▲|PM190.84+0.61 (+0.32%) ▲|QCOM197.24-1.03 (-0.52%) ▼|RTX192.19+1.20 (+0.63%) ▲|SBUX94.14-0.97 (-1.02%) ▼|SCHW99.50-0.85 (-0.85%) ▼|SO83.47-1.68 (-1.97%) ▼|SPG204.16-1.79 (-0.87%) ▼|T25.30+0.20 (+0.80%) ▲|TMO665.30+6.78 (+1.03%) ▲|TMUS165.66+3.25 (+2.00%) ▲|TSLA380.12+1.22 (+0.32%) ▲|TXN272.62+1.21 (+0.45%) ▲|UBER69.42-0.47 (-0.67%) ▼|UNH371.29-1.66 (-0.45%) ▼|UNP275.53+1.12 (+0.41%) ▲|UPS95.82-0.05 (-0.05%) ▼|USB58.48-0.96 (-1.62%) ▼|V361.52-0.52 (-0.14%) ▼|VZ46.52+0.07 (+0.15%) ▲|WFC81.90-1.25 (-1.50%) ▼|WMT110.53+0.41 (+0.37%) ▲|XOM161.23+2.52 (+1.59%) ▲|
12.6 C
New York
Thursday, September 24, 2026

Tag: world

newssourceFORcompanyinformationcontent1releasesmarket

Tevogen.AI Receives International Patent Publication for AI Technology Predicting Immunologically Active Peptides

WARREN, N.J., July 18, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) announced today that the International Bureau of the World Intellectual Property Organization (WIPO) has published its international patent application (Publication No. WO 2025/129197) titled, "Systems and Methods for Predicting Immunologically Active Peptides with Machine Learning Models."

CRUISE PLANNERS NAMED TO TRAVEL WEEKLY’S 2025 POWER LIST, RANKS #24 AMONG NATION’S TOP TRAVEL AGENCIES

CORAL SPRINGS, Fla., July 18, 2025 /PRNewswire/ -- Cruise Planners, the nation's largest home-based travel franchise network, has once again secured its position among the...

EXPLORA JOURNEYS RETURNS TO MONACO FOR FORMULA 1® GRAND PRIX DE MONACO 2026

After a landmark debut in 2025, Explora Journeys elevates the experience of ocean travel and motorsport luxury once again in the heart of Monte...

Wendy Luk Launches Soul Mission Alignment Program to Guide Spiritually Minded Professionals Into Their Higher Calling

An eight-week spiritual purpose coaching program that blends quantum healing, intuitive guidance, soul activations for Lightworkers, Starseeds, and mission-driven professionals ready to align with...

Monster Energy’s UNLEASHED Podcast Welcomes BMX Athletes Jamie Bestwick and Andy Buckworth on Special Live Episode at X Games Salt Lake City 2025

Episode 505 of the Sports and Pop Culture Podcast Recorded Live at X Games Salt Lake City 2025 SALT LAKE CITY, July 18, 2025 /PRNewswire/...

Anosh Inc Foundation Announces Illinois-Based Super PAC to Support Community-Focused Policy Priorities

New initiative aims to promote reforms in public safety, tax policy, and fiscal transparency through nonpartisan civic engagement.

Disclosure of notification received from Alychlo

Regulated information
Nazareth (Belgium)/Rotterdam (The Netherlands), 18 July 2025 – 6 PM CET

Fortnite Got Milk – With Dairy MAX

Dairy MAX's "Diner Tycoon" Is Out Now, Aiming To Put Dairy Back On The Map For Gen Z GRAND PRAIRIE, Texas, July 18, 2025 /PRNewswire/ --...

The American College of Surgeons Advances New Clinical Data Strategy to Improve Surgical Care for Patients

Collaboration with Epic is first phase of a multiyear project that will include multiple technology partners CHICAGO, July 18, 2025 /PRNewswire/ -- Long recognized as...

Dr Benoit Benoit Orthopedic Clinic: A New Vision of Personalized Surgical Care in Canada

Experienced Surgeon, Compassionate Team, Whole-Person Care. MONTREAL, July 18, 2025 /CNW/ - As access to care becomes increasingly complex, the Dr Benoit Benoit Orthopedic Clinic,...

European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms – 
– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms – 
– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

Residents of Watercrest Palm Beach Gardens Flourish Under the Leadership of Executive Director Tim Pierelli

VERO BEACH, Fla., July 18, 2025 /PRNewswire/ -- In the nine months since Watercrest Senior Living took operation of the newly re-branded Watercrest Palm...

Photonic Quantum Computing to Reach US$6.8 Billion by 2035 – PsiQuantum Leads as Photonic Quantum Vendors Rise

Explore the burgeoning world of Photonic Quantum Computers: these cost-effective, room-temperature machines promise significant growth, with revenues projected to soar from $1.1 billion in 2030 to $6.8 billion by 2035. Get insights on key players like PsiQuantum and market forecasts, covering vendors and components in a booming industry. 
Explore the burgeoning world of Photonic Quantum Computers: these cost-effective, room-temperature machines promise significant growth, with revenues projected to soar from $1.1 billion in 2030 to $6.8 billion by 2035. Get insights on key players like PsiQuantum and market forecasts, covering vendors and components in a booming industry.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsWorld

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers